Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 3
2005 2
2006 3
2007 2
2008 3
2009 2
2010 4
2011 2
2012 1
2013 3
2014 4
2015 4
2016 3
2017 4
2018 4
2019 6
2020 3
2021 7
2022 9
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Results by year

Filters applied: . Clear all
Page 1
Post-COVID-19 Hyposmia Does Not Exhibit Main Neurodegeneration Markers in the Olfactory Pathway.
Schirinzi T, Maftei D, Maurizi R, Albanese M, Simonetta C, Bovenzi R, Bissacco J, Mascioli D, Boffa L, Di Certo MG, Gabanella F, Francavilla B, Di Girolamo S, Mercuri NB, Passali FM, Lattanzi R, Severini C. Schirinzi T, et al. Among authors: severini c. Mol Neurobiol. 2024 Apr 4. doi: 10.1007/s12035-024-04157-w. Online ahead of print. Mol Neurobiol. 2024. PMID: 38570429
Reduced expression of secretogranin VGF in laryngeal squamous cell carcinoma.
Gabanella F, Maftei D, Colizza A, Rullo E, Riminucci M, Pasqualucci E, Di Certo MG, Lattanzi R, Possenti R, Corsi A, Greco A, De Vincentiis M, Severini C, Ralli M. Gabanella F, et al. Among authors: severini c. Oncol Lett. 2023 Nov 30;27(1):37. doi: 10.3892/ol.2023.14170. eCollection 2024 Jan. Oncol Lett. 2023. PMID: 38108073 Free PMC article.
Olfactory Neuron Substance P is Overexpressed in Parkinson's Disease Reflecting Gut Dysfunction.
Schirinzi T, Maftei D, Grillo P, Bovenzi R, Bissacco J, Simonetta C, Mascioli D, Zenuni H, Cerroni R, Vincenzi M, Maurizi R, Passali FM, Di Girolamo S, Ralli M, Magliulo G, Tirassa P, Stefani A, Mercuri NB, Lattanzi R, Severini C. Schirinzi T, et al. Among authors: severini c. Mov Disord. 2023 Jul;38(7):1364-1366. doi: 10.1002/mds.29433. Epub 2023 May 8. Mov Disord. 2023. PMID: 37157902 No abstract available.
Substance P and Prokineticin-2 are overexpressed in olfactory neurons and play differential roles in persons with persistent post-COVID-19 olfactory dysfunction.
Schirinzi T, Lattanzi R, Maftei D, Grillo P, Zenuni H, Boffa L, Albanese M, Simonetta C, Bovenzi R, Maurizi R, Loccisano L, Vincenzi M, Greco A, Di Girolamo S, Mercuri NB, Passali FM, Severini C. Schirinzi T, et al. Among authors: severini c. Brain Behav Immun. 2023 Feb;108:302-308. doi: 10.1016/j.bbi.2022.12.017. Epub 2022 Dec 19. Brain Behav Immun. 2023. PMID: 36549578 Free PMC article.
Nrf2 Pathway in Huntington's Disease (HD): What Is Its Role?
Tucci P, Lattanzi R, Severini C, Saso L. Tucci P, et al. Among authors: severini c. Int J Mol Sci. 2022 Dec 3;23(23):15272. doi: 10.3390/ijms232315272. Int J Mol Sci. 2022. PMID: 36499596 Free PMC article. Review.
Olfactory Neuron Prokineticin-2 as a Potential Target in Parkinson's Disease.
Schirinzi T, Maftei D, Passali FM, Grillo P, Zenuni H, Mascioli D, Maurizi R, Loccisano L, Vincenzi M, Rinaldi AM, Ralli M, Di Girolamo S, Stefani A, Lattanzi R, Severini C, Mercuri NB. Schirinzi T, et al. Among authors: severini c. Ann Neurol. 2023 Jan;93(1):196-204. doi: 10.1002/ana.26526. Epub 2022 Oct 26. Ann Neurol. 2023. PMID: 36218142
Investigational drugs for the treatment of olfactory dysfunction.
Di Stadio A, Severini C, Colizza A, De Vincentiis M, La Mantia I. Di Stadio A, et al. Among authors: severini c. Expert Opin Investig Drugs. 2022 Sep;31(9):945-955. doi: 10.1080/13543784.2022.2113054. Epub 2022 Aug 19. Expert Opin Investig Drugs. 2022. PMID: 35983993
68 results